NFE2L2 and myocardial infarction: Interestingly, earlier experimental evidence supports the utility of Nrf2 as a lead target for drug development to further improve treatment outcomes for MI and reperfusion (Z. Jiang et al., 2020; Q. Zhang et al., 2022).